Bioseparations and Downstream Processing
Purification of IgG and albumin from human plasma by aqueous two phase system fractionation
Article first published online: 22 JUN 2012
DOI: 10.1002/btpr.1565
Copyright © 2012 American Institute of Chemical Engineers (AIChE)
Additional Information
How to Cite
Vargas, M., Segura, Á., Herrera, M., Villalta, M., Angulo, Y., Gutiérrez, J. M., León, G. and Burnouf, T. (2012), Purification of IgG and albumin from human plasma by aqueous two phase system fractionation. Biotechnol Progress, 28: 1005–1011. doi: 10.1002/btpr.1565
Publication History
- Issue published online: 7 AUG 2012
- Article first published online: 22 JUN 2012
- Accepted manuscript online: 23 MAY 2012 01:31AM EST
- Manuscript Revised: 7 MAY 2012
- Manuscript Received: 1 FEB 2012
Funded by
- Vicerrectoría de Investigación Universidad de Costa Rica. Grant Number: project 741-B0-113
- Abstract
- Article
- References
- Cited By
Keywords:
- IgG;
- albumin;
- aqueous two phase system;
- plasma fractionation
Abstract
The current shortages in human plasma products at global levels justify the development of new, cost effective plasma fractionation methods. We have developed a fractionation process to obtain immunoglobulin G (IgG) and albumin-enriched fractions based on polymer-salt aqueous two phase system (ATPS). A small-scale (0.02 L) ATPS composed of polyethyleneglycol 3350 (PEG), potassium phosphate and sodium chloride, at pH 6.1, was evaluated and subjected to 50-fold scale-up (1 L). Further purification of the fractions was performed using caprylic acid precipitation and ion exchange chromatography. Similar yield and purity were obtained at both small and large scales. IgG precipitated in the PEG rich upper phase at 83% recovery and 2.75-fold purification factor. An 81% pure albumin fraction was obtained in the salt rich bottom phase with a 91% yield. After polishing, IgG was obtained at a recovery of 70% and a purity of 92%. Corresponding values for albumin were 91% and 90%. This IgG and albumin fractionation technology deserves further evaluation as it may represent a potential alternative to conventional plasma fractionation methods. © 2012 American Institute of Chemical Engineers Biotechnol. Prog., 28: 1005–1011, 2012

1520-6033/asset/BTPR_left.gif?v=1&s=a5be2ff5a0fe6ccdaad74a6d128c142e5f71a8da)
1520-6033/asset/BTPR_right.gif?v=1&s=992d113a3e61fc9d3571812359165df86cf830e4)
